After the April 2022 virtual advanced market commitment (AMC) Summit, donors mobilized a total of US$4.8 billion to replenish COVAX. Commentary from the Donor Tracker breaks down funding sources and program priorities.

With the election of Yoon Suk-yeol from the main opposition, People Power Party, as the 20th president of South Korea on March 9, 2022, the SEEK team considers the new president's impact on South Korea's ODA and international development assistance strategies.

After 100 days in office, on March 16, 2022, the Cabinet of Germany’s ‘traffic light’ coalition — made up of the Social Democrats (SPD), the Greens, and the Free Democratic Party (FDP) — adopted a second draft of the 2022 federal budget. Worth €457.6 billion (US$517.2 billion), this draft budget implies a 20.1% decrease in government spending compared to the overall federal budget for 2021, which was developed under the former government led by Angela Merkel. 

The SEEK team analyzes this new budget, its decrease, and the implications for Germany’s development cooperation in 2022 and beyond, especially against the backdrop of COVID-19 and war in Ukraine.

Every year since 2007, the G-FINDER project has provided policymakers, donors, researchers, and the pharmaceutical industry with a comprehensive analysis of global investment in research and development (R&D) of new products to prevent, diagnose, control, or cure neglected diseases in low- and middle-income countries (LMICs).

This ‘Partner Perspective’ draws on the findings from the fourteenth annual G-FINDER report, launched on January 27, 2022, by Policy Cures Research (PCR), an Australia-based research and policy institute, which presents data on investments made in 2020.